Terrie Kellmeyer
CIK: 0002135020
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AVXL
ANAVEX LIFE SCIENCES CORP.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Kellmeyer Terrie
Kellmeyer Terrie (SEC CIK 0002135020) files insider reports with the SEC as Interim CEO of ANAVEX LIFE SCIENCES CORP. (AVXL).
Signal8 holds 1 ownership filing by Kellmeyer Terrie, a Form 3, filed on May 14, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Kellmeyer Terrie's filings is in NEW YORK, NY.
Other insiders filing for ANAVEX LIFE SCIENCES CORP. (AVXL)
- Senderowicz Adrian, Director
- Patel Gautam, Director
- Boenisch Sandra, PFO & Treasurer
- Paeger Axel, Director
- MISSLING CHRISTOPHER U, President and CEO
- Thomas Steffen, Director